Cassava Sciences Company Insiders

SAVA Stock  USD 3.98  0.15  3.92%   
Cassava Sciences' insiders are aggressively buying. The analysis of insiders' sentiment of trading Cassava Sciences stock suggests that vertually all insiders are extremely bullish at this time. Cassava Sciences employs about 29 people. The company is managed by 13 executives with a total tenure of roughly 32 years, averaging almost 2.0 years of service per executive, having 2.23 employees per reported executive.
Remi Barbier  Chairman
Chairman of the Board and Presidentident, CEO

Cassava Sciences' Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-08-23Sanford RobertsonAcquired 42000 @ 12.46View
2023-08-21Richard BarryAcquired 2668 @ 12View
2023-03-06Richard BarryAcquired 16190 @ 18.66View
2022-08-23Richard BarryAcquired 50622 @ 16.99View
2022-08-12Sanford RobertsonAcquired 140000 @ 14.78View
Monitoring Cassava Sciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

Cassava Sciences' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Cassava Sciences' future performance. Based on our forecasts, it is anticipated that Cassava will maintain a workforce of about 30 employees by December 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Cassava Sciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.456) % which means that it has lost $0.456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1098) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences' management efficiency ratios could be used to measure how well Cassava Sciences manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.61. The current year's Return On Capital Employed is expected to grow to -0.73. At present, Cassava Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 7.9 M, whereas Total Assets are forecasted to decline to about 114.4 M.
The current year's Common Stock Shares Outstanding is expected to grow to about 44 M, whereas Net Loss is projected to grow to (65.2 M).

Cassava Sciences Workforce Comparison

Cassava Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 5,226. Cassava Sciences maintains roughly 29.0 in number of employees contributing less than 1% to equities under Health Care industry.

Cassava Sciences Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cassava Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cassava Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cassava Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
3.4
17
5
 443,085 
 170,390 
2023-06-01
2.25
18
8
 227,358 
 142,551 
2023-03-01
1.0
4
4
 95,983 
 12,281 
2022-12-01
2.0
2
1
 109,376 
 9,376 
2022-09-01
4.0
4
1
 141,159 
 2,802 
2022-06-01
0.8
4
5
 139,341 
 191,046 
2022-03-01
2.0
2
1
 9,339 
 4,024 
2021-09-01
0.6667
2
3
 5,602 
 7,348 
2021-06-01
0.5
1
2
 56,030 
 109,995 
2021-03-01
0.6667
4
6
 40,156 
 68,539 
2018-12-01
0.5
1
2
 50,000 
 512,660 
2018-09-01
1.375
11
8
 275,000 
 4,676,000 
2014-12-01
7.0
7
1
 1,250,000 
 5,000 
2014-09-01
0.5
4
8
 864,599 
 1,624,623 
2014-06-01
3.5
14
4
 1,579,951 
 302,095 
2014-03-01
1.6667
5
3
 180,167 
 102,727 
2013-06-01
2.7778
25
9
 1,602,087 
 318,230 
2011-12-01
0.8333
5
6
 66,820 
 422,000 
2011-09-01
1.3333
8
6
 1,127,671 
 704,501 
2011-06-01
1.5455
17
11
 1,537,081 
 1,345,876 
2011-03-01
0.6667
4
6
 109,971 
 184,939 
2010-12-01
2.5
5
2
 54,626 
 50,000 
2010-09-01
0.6
9
15
 638,000 
 143,360 
2010-06-01
0.7826
18
23
 156,743 
 273,479 
2010-03-01
0.5
7
14
 120,939 
 298,800 
2009-12-01
0.1818
2
11
 100,000 
 130,000 
2009-09-01
0.3462
9
26
 685,800 
 6,976,308 
2009-06-01
0.0845
6
71
 106,748 
 2,834,279 
2009-03-01
0.0714
1
14
 25,000 
 1,125,000 
2008-12-01
0.4286
3
7
 17,442 
 152,500 
2008-09-01
1.5
9
6
 445,574 
 150,000 
2008-06-01
1.8333
11
6
 938,163 
 150,000 
2008-03-01
1.3636
15
11
 255,500 
 223,400 
2007-12-01
0.6667
4
6
 81,219 
 150,000 
2007-09-01
1.875
15
8
 157,211 
 200,000 
2007-06-01
1.25
15
12
 1,010,270 
 210,000 
2007-03-01
2.9231
38
13
 990,761 
 172,000 
2006-12-01
0.6923
9
13
 255,323 
 181,000 
2006-09-01
0.8182
9
11
 82,664 
 173,000 
2006-06-01
3.3
33
10
 1,622,397 
 166,000 
2006-03-01
0.0698
3
43
 36,555 
 148,054 
2005-12-01
7.0
21
3
 285,964 
 35,000 
2005-06-01
7.5
15
2
 1,006,884 
 43,000 
2004-12-01
2.0
2
1
 18,093 
 25,000 
2004-09-01
8.0
8
1
 935,000 
 10,800 
2003-09-01
9.0
9
1
 559,504 
 94,985 

Cassava Sciences Notable Stakeholders

A Cassava Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cassava Sciences often face trade-offs trying to please all of them. Cassava Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cassava Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Remi BarbierChairman of the Board and Presidentident, CEOProfile
Christopher JDCompany VPProfile
James MDChief OfficerProfile
Michael ZamlootSenior OperationsProfile
Jaren LandenChief OfficerProfile
Michael PharmDSenior AffairsProfile
Lindsay BurnsSenior NeuroscienceProfile
Christopher CookSr CounselProfile
Eric SchoenChief OfficerProfile
Nadav MDChief DirectorProfile
Freda NassifChief OfficerProfile
Richard BarryExecutive BoardProfile
George ThorntonSenior TechnologyProfile

About Cassava Sciences Management Performance

The success or failure of an entity such as Cassava Sciences often depends on how effective the management is. Cassava Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cassava management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cassava management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.64)(0.61)
Return On Capital Employed(0.77)(0.73)
Return On Assets(0.64)(0.61)
Return On Equity(0.71)(0.67)
Please note, the presentation of Cassava Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cassava Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cassava Sciences' management manipulating its earnings.

Cassava Sciences Workforce Analysis

Traditionally, organizations such as Cassava Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cassava Sciences within its industry.

Cassava Sciences Manpower Efficiency

Return on Cassava Sciences Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee3.4M
Net Loss Per Executive7.5M
Working Capital Per Employee4M
Working Capital Per Executive8.9M

Complementary Tools for Cassava Stock analysis

When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Transaction History
View history of all your transactions and understand their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios